244 related articles for article (PubMed ID: 26008603)
1. Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.
Kshettry VR; Ostrom QT; Kruchko C; Al-Mefty O; Barnett GH; Barnholtz-Sloan JS
Neuro Oncol; 2015 Aug; 17(8):1166-73. PubMed ID: 26008603
[TBL] [Abstract][Full Text] [Related]
2. Descriptive Epidemiology of Spinal Meningiomas in the United States.
Kshettry VR; Hsieh JK; Ostrom QT; Kruchko C; Benzel EC; Barnholtz-Sloan JS
Spine (Phila Pa 1976); 2015 Aug; 40(15):E886-9. PubMed ID: 25996535
[TBL] [Abstract][Full Text] [Related]
3. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.
Brown DA; Goyal A; Kerezoudis P; Alvi MA; Himes BT; Bydon M; Van Gompel JJ; Chaichana KL; Quiñones-Hinojosa A; Burns TC; Yan E; Parney IF
J Neurooncol; 2020 Sep; 149(2):293-303. PubMed ID: 32860156
[TBL] [Abstract][Full Text] [Related]
5. WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.
Ressel A; Fichte S; Brodhun M; Rosahl SK; Gerlach R
J Neurooncol; 2019 Nov; 145(2):277-286. PubMed ID: 31578671
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptor in meningiomas: An immunohistochemical analysis.
Telugu RB; Chowhan AK; Rukmangadha N; Patnayak R; Phaneendra BV; Mowliswara Prasad BC; Reddy MK
J Cancer Res Ther; 2020; 16(6):1482-1487. PubMed ID: 33342817
[TBL] [Abstract][Full Text] [Related]
7. Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018.
Recker MJ; Kuo CC; Prasad D; Attwood K; Plunkett RJ
J Neurooncol; 2022 Oct; 160(1):13-22. PubMed ID: 35819682
[TBL] [Abstract][Full Text] [Related]
8. Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017.
Withrow DR; Devesa SS; Deapen D; Petkov V; Van Dyke AL; Adamo M; Armstrong TS; Gilbert MR; Linet MS
Cancer; 2021 Oct; 127(19):3579-3590. PubMed ID: 34160068
[TBL] [Abstract][Full Text] [Related]
9. Demographic and socioeconomic disparities of benign and malignant spinal meningiomas in the United States.
Ghaffari-Rafi A; Mehdizadeh R; Ghaffari-Rafi S; Leon-Rojas J
Neurochirurgie; 2021 Apr; 67(2):112-118. PubMed ID: 33068594
[TBL] [Abstract][Full Text] [Related]
10. WHO classification of meningiomas-A single institutional experience.
Salami AA; Okunlola AI; Ajani MA; Onakpoma F
Neurochirurgie; 2021 Apr; 67(2):119-124. PubMed ID: 33144180
[TBL] [Abstract][Full Text] [Related]
11. Histopathological classification and location of consecutively operated meningiomas at a single institution in China from 2001 to 2010.
Wang DJ; Xie Q; Gong Y; Mao Y; Wang Y; Cheng HX; Zhong P; Che XM; Jiang CC; Huang FP; Zheng K; Li SQ; Gu YX; Bao WM; Yang BJ; Wu JS; Xie LQ; Zheng MZ; Tang HL; Zhu HD; Chen XC; Zhou LF
Chin Med J (Engl); 2013 Feb; 126(3):488-93. PubMed ID: 23422112
[TBL] [Abstract][Full Text] [Related]
12. The impact of brain invasion criteria on the incidence and distribution of WHO grade 1, 2, and 3 meningiomas.
Rebchuk AD; Chaharyn BM; Alam A; Hounjet CD; Gooderham PA; Yip S; Makarenko S
Neuro Oncol; 2022 Sep; 24(9):1524-1532. PubMed ID: 35139206
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act.
Dolecek TA; Dressler EV; Thakkar JP; Liu M; Al-Qaisi A; Villano JL
Cancer; 2015 Jul; 121(14):2400-10. PubMed ID: 25872752
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
van de Nes JA; Griewank KG; Schmid KW; Grabellus F
Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
[TBL] [Abstract][Full Text] [Related]
15. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
16. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994.
Surawicz TS; McCarthy BJ; Kupelian V; Jukich PJ; Bruner JM; Davis FG
Neuro Oncol; 1999 Jan; 1(1):14-25. PubMed ID: 11554386
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and survival of patients with spinal meningiomas: A SEER analysis.
Cao Y; Jiang Y; Liu C; Jin R; Jin Z; Hong X; Zhao L; Zhao G; Wang Y
Eur J Surg Oncol; 2021 Sep; 47(9):2340-2345. PubMed ID: 33546961
[TBL] [Abstract][Full Text] [Related]
18. Trends in intracranial meningioma incidence in the United States, 2004-2015.
Lin DD; Lin JL; Deng XY; Li W; Li DD; Yin B; Lin J; Zhang N; Sheng HS
Cancer Med; 2019 Oct; 8(14):6458-6467. PubMed ID: 31475482
[TBL] [Abstract][Full Text] [Related]
19. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
20. The accuracy of meningioma grading: a 10-year retrospective audit.
Willis J; Smith C; Ironside JW; Erridge S; Whittle IR; Everington D
Neuropathol Appl Neurobiol; 2005 Apr; 31(2):141-9. PubMed ID: 15771707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
